KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,988,322 | -22.3% | 35,415 | -0.4% | 0.02% | -19.2% |
| Q2 2023 | $7,707,066 | +127.8% | 35,541 | +90.8% | 0.03% | +116.7% |
| Q1 2023 | $3,383,590 | -58.2% | 18,628 | -54.7% | 0.01% | -58.6% |
| Q4 2022 | $8,088,923 | -56.6% | 41,165 | -50.3% | 0.03% | -21.6% |
| Q3 2022 | $18,618,178 | +54.2% | 82,774 | -13.3% | 0.04% | +68.2% |
| Q2 2022 | $12,076,449 | -2.1% | 95,462 | -1.9% | 0.02% | +22.2% |
| Q1 2022 | $12,339,601 | +26.5% | 97,320 | +30.7% | 0.02% | -28.0% |
| Q4 2021 | $9,756,000 | +8.4% | 74,471 | +1.2% | 0.02% | 0.0% |
| Q3 2021 | $9,001,000 | -44.3% | 73,582 | -48.1% | 0.02% | +8.7% |
| Q2 2021 | $16,158,000 | +89.4% | 141,746 | +99.7% | 0.02% | -11.5% |
| Q1 2021 | $8,533,000 | +59.0% | 70,975 | +34.4% | 0.03% | +52.9% |
| Q4 2020 | $5,365,000 | +36.9% | 52,809 | +4.2% | 0.02% | +21.4% |
| Q3 2020 | $3,919,000 | -65.6% | 50,683 | -50.4% | 0.01% | -36.4% |
| Q2 2020 | $11,380,000 | – | 102,092 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |